Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.
Jose MateusAlba GrifoniAlison TarkeJohn SidneySydney I RamirezJennifer M DanZoe C BurgerStephen A RawlingsDavey M SmithElizabeth Jane PhillipsSimon A MallalMarshall LammersPaul RubiroLorenzo QuiambaoAaron SutherlandEsther Dawen YuRicardo da Silva AntunesJason A GreenbaumApril FrazierAlena Janda MarkmannLakshmanane PremkumarArivianda M DeSilvaBjoern PetersShane CrottyAlessandro SetteDaniela WeiskopfPublished in: Science (New York, N.Y.) (2020)
Many unknowns exist about human immune responses to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2-reactive CD4+ T cells have been reported in unexposed individuals, suggesting preexisting cross-reactive T cell memory in 20 to 50% of people. However, the source of those T cells has been speculative. Using human blood samples derived before the SARS-CoV-2 virus was discovered in 2019, we mapped 142 T cell epitopes across the SARS-CoV-2 genome to facilitate precise interrogation of the SARS-CoV-2-specific CD4+ T cell repertoire. We demonstrate a range of preexisting memory CD4+ T cells that are cross-reactive with comparable affinity to SARS-CoV-2 and the common cold coronaviruses human coronavirus (HCoV)-OC43, HCoV-229E, HCoV-NL63, and HCoV-HKU1. Thus, variegated T cell memory to coronaviruses that cause the common cold may underlie at least some of the extensive heterogeneity observed in coronavirus disease 2019 (COVID-19) disease.